These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 12935295)
41. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4. Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168 [TBL] [Abstract][Full Text] [Related]
42. DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells. de Winter JP; Roelen BA; ten Dijke P; van der Burg B; van den Eijnden-van Raaij AJ Oncogene; 1997 Apr; 14(16):1891-9. PubMed ID: 9150356 [TBL] [Abstract][Full Text] [Related]
43. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells. Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629 [TBL] [Abstract][Full Text] [Related]
44. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698 [TBL] [Abstract][Full Text] [Related]
45. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line. Tsang KJ; Tsang D; Brown TN; Crowe DL Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275 [TBL] [Abstract][Full Text] [Related]
46. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. Hunt KK; Fleming JB; Abramian A; Zhang L; Evans DB; Chiao PJ Cancer Res; 1998 Dec; 58(24):5656-61. PubMed ID: 9865717 [TBL] [Abstract][Full Text] [Related]
47. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. Hayashida T; Decaestecker M; Schnaper HW FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291 [TBL] [Abstract][Full Text] [Related]
48. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells. Buck MB; Pfizenmaier K; Knabbe C Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732 [TBL] [Abstract][Full Text] [Related]
49. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells. Choi JH; Hwang YP; Kim HG; Khanal T; Do MT; Jin SW; Han HJ; Lee HS; Lee YC; Chung YC; Jeong TC; Jeong HG Nutr Cancer; 2014; 66(1):140-51. PubMed ID: 24341702 [TBL] [Abstract][Full Text] [Related]
50. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Fink SP; Mikkola D; Willson JK; Markowitz S Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756 [TBL] [Abstract][Full Text] [Related]
52. Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair. Kanamoto T; Hellman U; Heldin CH; Souchelnytskyi S EMBO J; 2002 Mar; 21(5):1219-30. PubMed ID: 11867550 [TBL] [Abstract][Full Text] [Related]
53. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Xu MY; Porte J; Knox AJ; Weinreb PH; Maher TM; Violette SM; McAnulty RJ; Sheppard D; Jenkins G Am J Pathol; 2009 Apr; 174(4):1264-79. PubMed ID: 19147812 [TBL] [Abstract][Full Text] [Related]